Cargando…
Prevalence and correlates of stocking up on drugs during the COVID-19 pandemic: Data from the C3PNO Consortium
BACKGROUND: Data from the COVID-19 pandemic describes increases in drug use and related harms, especially fatal overdose. However, evidence is needed to better understand the pathways from pandemic-related factors to substance use behaviours. Thus, we investigated stockpiling drugs among people who...
Autores principales: | King, L., Hayashi, K., Genberg, B., Choi, J., DeBeck, K., Kirk, G., Mehta, SH, Kipke, M., Moore, RD, Baum, MK, Shoptaw, S., Gorbach, PM, Mustanski, B., Javanbakht, M., Siminski, S., Milloy, M-J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535877/ https://www.ncbi.nlm.nih.gov/pubmed/36266158 http://dx.doi.org/10.1016/j.drugalcdep.2022.109654 |
Ejemplares similares
-
Substance use and other factors associated with COVID-19 vaccine uptake among people at risk for or living with HIV: Findings from the C3PNO consortium
por: Javanbakht, Marjan, et al.
Publicado: (2023) -
COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts
por: Lesko, Catherine R., et al.
Publicado: (2022) -
The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts
por: Pytell, Jarratt D., et al.
Publicado: (2022) -
Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada()
por: Moallef, Soroush, et al.
Publicado: (2022) -
Use of COVID-19 testing in the first year of the COVID-19 pandemic among cohorts of people at the intersection of drug use and HIV
por: Gorbach, Pamina M., et al.
Publicado: (2022)